If Daly can have a popular thread for an unproven potential blockbuster drug (also possibly a pump-and-dump), I want a thread too, whaaaaaaaaaaaaaa!!!
Stock is almost 300% from $50 to just under $200 in the past few days.
Don't know why no one mentioned this yet. I'll try to pick it apart over time...
https://www.aljazeera.com/news/2020/...101243080.html
https://www.fiercebiotech.com/biotec...caveats-abound
From the press release:
https://www.synairgen.com/wp-content...mminently-.pdf
There is evidence that deficiency in IFN-beta production by the lung could
explain the enhanced susceptibility of these at-risk patient groups to developing severe
lower respiratory tract (lung) disease during respiratory viral infections.
I like that this points to this drug doing something about the differences between how young people get the disease and how older people (and people with underlying conditions). If we can figure that out and make the the second group as resilient as the first, we can effectively have this bastard on the ropes.
The odds of developing severe disease (e.g., requiring ventilation or resulting in death) during the treatment period (day 1 to day 16) were reduced by 79% for patients receiving SNG001 compared to placebo
Reply With Quote
